𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of denosumab on bone turnover markers in postmenopausal osteoporosis: Initial response and subsequent release from suppression

✍ Scribed by R. Eastell; M. Austin; J. San Martin; M.R. McClung; C. Christiansen; C. Libanati; E.S. Siris; S.R. Cummings


Book ID
116321647
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
163 KB
Volume
44
Category
Article
ISSN
8756-3282

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Effects of denosumab on bone turnover ma
✍ Richard Eastell; Claus Christiansen; Andreas Grauer; Stepan Kutilek; Cesar Liban πŸ“‚ Article πŸ“… 2011 πŸ› American Society for Bone and Mineral Research 🌐 English βš– 272 KB πŸ‘ 1 views

## Abstract Denosumab, a fully human monoclonal antibody to RANKL, decreases bone remodeling, increases bone density, and reduces fracture risk. This study evaluates the time course and determinants of bone turnover marker (BTM) response during denosumab treatment, the percentage of denosumab‐treat